Metapneumovirus
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus (NCT03502694) | Janssen Research & Development, LLC | 2018-11-05 |
| Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine (NCT01255410) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-01-01 |
Track Metapneumovirus automatically
Every clearance here is in the API, with alerts when new ones post.